ondansetron has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bakırcı, Ş | 1 |
Sağsöz, N | 1 |
Devrim, T | 1 |
Şahin, Y | 1 |
Bulanık, M | 1 |
Gözüyukarı, H | 1 |
1 other study available for ondansetron and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous
Article | Year |
---|---|
Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model.
Topics: Animals; Cabergoline; Dopamine Agonists; Endothelial Cells; Female; Humans; Ondansetron; Ovarian Hyp | 2022 |